1. Home
  2. SMBC vs AMPH Comparison

SMBC vs AMPH Comparison

Compare SMBC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Missouri Bancorp Inc.

SMBC

Southern Missouri Bancorp Inc.

HOLD

Current Price

$76.75

Market Cap

819.7M

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$21.78

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMBC
AMPH
Founded
1887
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.7M
971.8M
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
SMBC
AMPH
Price
$76.75
$21.78
Analyst Decision
Hold
Buy
Analyst Count
4
8
Target Price
$69.50
$28.38
AVG Volume (30 Days)
106.9K
614.5K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
1.47%
N/A
EPS Growth
N/A
N/A
EPS
4.59
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$16.09
$6.90
Revenue Next Year
$5.69
$4.64
P/E Ratio
$16.29
$150.29
Revenue Growth
N/A
N/A
52 Week Low
$47.60
$16.65
52 Week High
$75.50
$31.26

Technical Indicators

Market Signals
Indicator
SMBC
AMPH
Relative Strength Index (RSI) 71.13 61.84
Support Level $66.74 $16.84
Resistance Level N/A $24.61
Average True Range (ATR) 1.74 0.85
MACD 0.34 0.24
Stochastic Oscillator 82.42 85.85

Price Performance

Historical Comparison
SMBC
AMPH

About SMBC Southern Missouri Bancorp Inc.

Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: